Lucy Cobbs, MD Wills Eye Hospital Dr. Carl Regillo from Wills Eye Hospital / Mid-Atlantic Retina presented the 32-week primary outcomes of the Phase IIIb TALON study for the…
Prashant Tailor, MD Mayo Clinic Dr. Raj Maturi, MD presented on UBX1325, A Novel Senolytic Therapy for Treatment Experienced Patients With Chronic DME or Wet AMD: 24-Week Results of a…
Theo Bowe, MD Wills Eye Hospital Dr. Jeffrey Heier from Ophthalmic Consultants of Boston presented the ReCLAIM-2 trial, a phase 2 trial of elamipretide in patients with non-central geographic atrophy…
Frank Ma, MD, PhD PGY-3, University of California San Francisco ARVO closing keynote: Accelerating ophthalmic discovery and technology translation through team science To conclude a successful meeting in beautiful sunny…
Retinal Prostheses and Transplantation Session May 2nd, 2022; ARVO; Denver CO Drs. Jacob Light, Abtin Shahlaee, Meera Sivalingam Vitreoretinal Fellows Wills Eye Hospital One of the biggest challenges facing ophthalmic…
Retina Roundup DAZZLE KSI-301 Phase 3 Trial Summary Blake Fortes, MD PGY-3, Mayo Clinic Dr. Carl Regillo from Wills Eye Hospital presented the one-year results of the DAZZLE trial, a…
Nita Valikodath MD, MS Vitreoretinal Surgery Fellow Duke University Eye Center “The time you enjoy wasting is not time wasted” was the title of Session 3: the Debates section of…
David Xu, MD Vitreoretinal Surgery Wills Eye Hospital Dr. David Brown presented the one-year results of the phase 2, randomized, single-masked study of high dose aflibercept for neovascular age-related macular…